SCHEMBL7689857

SCHEMBL7689857

O=C1CNc2cc3ccccc3cc2N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.51
CYP11B2 P19099 2/20 0.51
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
CASP1 P29466 1/20 0.44
MPI P34949 1/20 0.44
HTT P42858 1/20 0.44
CASP7 P55210 1/20 0.44
HSD17B10 Q99714 1/20 0.44
AHR P35869 2/20 0.39
PDK2 Q15119 1/20 0.39
RAF1 P04049 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29483964 0.79 AHR (0.50) CYP11B1CYP11B2MEN1KMT2AALDH1A1
SCHEMBL37900 0.79 AHR (0.50) CYP11B1CYP11B2MEN1KMT2AALDH1A1
SCHEMBL31483510 0.78 CYP11B1 (0.46) CYP11B1CYP11B2ALDH1A1TP53AHR
SCHEMBL14361898 0.75 CYP11B1 (0.42) CYP11B1CYP11B2TP53AHRRAF1
SCHEMBL17348364 0.75 CYP11B1 (0.42) CYP11B1CYP11B2MEN1KMT2AALDH1A1
SCHEMBL29007518 0.74 CYP11B1 (0.70) CYP11B1CYP11B2MEN1KMT2AALDH1A1
SCHEMBL30724416 0.74 PDE3B (0.55) CYP11B1CYP11B2ALDH1A1TP53SMYD3
SCHEMBL3350612 0.74 PDE3B (0.55) CYP11B1CYP11B2ALDH1A1TP53SMYD3
SCHEMBL9921312 0.72 MAPT (0.56) MEN1KMT2AALDH1A1GAALMNA
SCHEMBL30076196 0.72 MAPT (0.56) MEN1KMT2AALDH1A1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO claimed
US-20200385370-A1 APPARATUS FOR REMOVING BAD ODOR FROM TOILET SYNBLIA THERAPEUTICS, INC. 2020-12-10 US disclosed
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200385370-A1 APPARATUS FOR REMOVING BAD ODOR FROM TOILET IRAK4, IRAK1, IRAK2 CYP11B1 1887/4885CYP11B2 2343/4885MEN1 2754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.